title: Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
abstract: Hepatitis B virus (HBV) replicates via an intermediate RNA step. High frequency of polymerase errors with additional selection pressure leads to mutations in the HBV genome. We investigated the number, type, and antigenic effects of mutations in the coding region of the HBV surface antigen in eight patients who underwent orthotopic liver transplantation (OLT) for HBV-related end-stage liver disease and were experiencing infection of the graft and who received hepatitis B surface antigen antibody (anti-HBs) prophylaxis (hepatitis B immune globulin [HBIG]) after OLT. Controls were chronic HBV patients who underwent kidney transplantation and received the same immunosuppressive regime but no HBIG. The S-gene was amplified from serum before and after transplantation, sequenced, and changes in the genome were analyzed. In the five patients who experienced reinfection while receiving anti-HBs, clear mutations occurred in the S-gene. In the patient who did not receive HBIG and those who experienced reinfection only after termination of HBIG, no mutations were found in the S-gene. In the kidney recipients, mutations in the S-gene occurred in only one of eight patients. Because the a determinant contains neutralizing epitopes, this region was chosen for antibody binding to quantify antigenic effects of the mutations. The two patients who selected mutations in the a determinant and became reinfected while receiving HBIG had reduced antibody binding after OLT. Our results suggest that HBIG after OLT imposes a selection pressure on the S-gene, and that mutations are one mechanism for reinfection while receiving HBIG.
authors.affiliation: Institute of Virology, University of Glasgow, Scotland.
authors.forename: W F
authors.initials: WF
authors.lastname: Carman
authors.forename: C
authors.initials: C
authors.lastname: Trautwein
authors.forename: F J
authors.initials: FJ
authors.lastname: van Deursen
authors.forename: K
authors.initials: K
authors.lastname: Colman
authors.forename: E
authors.initials: E
authors.lastname: Dornan
authors.forename: G
authors.initials: G
authors.lastname: McIntyre
authors.forename: J
authors.initials: J
authors.lastname: Waters
authors.forename: V
authors.initials: V
authors.lastname: Kliem
authors.forename: R
authors.initials: R
authors.lastname: Müller
authors.forename: H C
authors.initials: HC
authors.lastname: Thomas
authors.forename: M P
authors.initials: MP
authors.lastname: Manns
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D000939:Epitopes; D014644:Genetic Variation; D016679:Genome, Viral; D006509:Hepatitis B / Q000517:prevention & control*; D006513:Hepatitis B e Antigens / Q000235:genetics* / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D007165:Immunosuppression Therapy; D016031:Liver Transplantation; D008969:Molecular Sequence Data; D009154:Mutation; D016133:Polymerase Chain Reaction; D011184:Postoperative Period; D012008:Recurrence
chemical_list: D000939:Epitopes; D006513:Hepatitis B e Antigens; D007136:Immunoglobulins; C045213:hepatitis B hyperimmune globulin